Acne Keloidalis Nuchae Successfully Treated with Halobetasol 0.01% and Tazarotene 0.045% Lotion

Main Article Content

Olga Marushchak https://orcid.org/0000-0001-8858-5987
Kathryn Jayne Tan
Maria Rosa Noliza Encarnacion
Loren Clark
Alexandra Golant

Keywords

acne keloidalis nuchae, halobetasol/tazarotene lotion

Abstract

Acne keloidalis nuchae (AKN) is an idiopathic chronic inflammatory condition that predominantly affects African-American men and presents with follicular papules, pustules and plaques, which may eventually lead to keloid-like scarred lesions, fibrotic plaques, abscesses, sinuses, and alopecia. Conventional treatment approach focuses on avoidance of exacerbation factors, utilization of topical and oral antibiotics, and decreasing inflammation with intralesional steroids. This is the first case showing successful treatment of AKN with halobetasol 0.01% and tazarotene 0.045% lotion. Although topical steroids and topical retinoids have been used as treatment options, there are no published data supporting the use of their fixed combination in patients with AKN.

References

1. Otberg N, Shapiro J. Cicatricial Alopecias. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, Orringer JS. eds. Fitzpatrick's Dermatology, 9e. McGraw-Hill; Accessed February 12, 2021.

2. Maranda EL, Simmons BJ, Nguyen AH, Lim VM, Keri JE. Treatment of Acne Keloidalis Nuchae: A Systematic Review of the Literature. Dermatol Ther. 2016;6(3):363–378. doi:10.1007/s13555-016-0134-5

3. Sperling LC, Homoky C, Pratt L, Sau P. Acne Keloidalis Is a Form of Primary Scarring Alopecia. Arch Dermatol. 2000;136(4):479–484. doi:10.1001/archderm.136.4.479

4. Callender VD, Young CM, Haverstock CL, Carroll CL, Feldman SR. An open label study of clobetasol propionate 0.05% and betamethasone valerate 0.12% foams in the treatment of mild to moderate acne keloidalis. Cutis. 2005 Jun;75(6):317-21 PMID: 16047868.

5. Ogunbiyi A. Acne keloidalis nuchae: prevalence, impact, and management challenges. Clin Cosmet Investig Dermatol. 2016 Dec;9:483-489. doi:10.2147/CCID.S99225

6. Beckett N, Lawson C, Cohen G. Electrosurgical excision of acne keloidalis nuchae with secondary intention healing. J Clin Aesthet Dermatol. 2011 Jan;4(1):36-39

7. Esmat SM, Abdel Hay RM, Abu Zeid OM, Hosni HN. The efficacy of laser-assisted hair removal in the treatment of acne keloidalis nuchae; a pilot study. Eur J Dermatol. 2012;22(5):645-650. doi:10.1684/ejd.2012.1830

8. Dragoni F, Bassi A, Cannarozzo G, Bonan P, Moretti S, Campolmi P. Successful treatment of acne keloidalis nuchae resistant to conventional therapy with 1064-nm ND:YAG laser. G Ital Dermatol Venereol. 2013;148(2):231-232.

9. Shah GK. Efficacy of diode laser for treating acne keloidalis nuchae. Indian J Dermatol Venereol Leprol. 2005;71(1):31-34. doi:10.4103/0378-6323.13783

10. Okoye GA, Rainer BM, Leung SG, et al. Improving acne keloidalis nuchae with targeted ultraviolet B treatment: a prospective, randomized, split-scalp comparison study. Br J Dermatol. 2014;171(5):1156-1163. doi:10.1111/bjd.13119

11. Millán-Cayetano JF, Repiso-Jiménez JB, Del Boz J, de Troya-Martín M. Refractory acne keloidalis nuchae treated with radiotherapy. Australas J Dermatol. 2017;58(1):e11-e13. doi:10.1111/ajd.12380

12. Gloster HM Jr. The surgical management of extensive cases of acne keloidalis nuchae. Arch Dermatol. 2000;136(11):1376-1379. doi:10.1001/archderm.136.11.1376

Similar Articles

You may also start an advanced similarity search for this article.